Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1569 ARTÍCULOS , VIENDO DEL 1276 AL 1290

Microglia-Mediated Neuroprotection, TREM2, and Alzheimer's Disease: Evidence From Optical Imaging

Condello C, Yuan P, Grutzendler J.

Biol Psychiatry. 2018 Feb 15;83(4):377-387. doi: 10.1016/j.biopsych.2017.10.007. Epub 2017 Oct 14.

Impaired peripheral glucose homeostasis and Alzheimer's disease

Wijesekara N, Gonçalves RA, De Felice FG, Fraser PE.

Neuropharmacology. 2018 Jul 1;136(Pt B):172-181. doi: 10.1016/j.neuropharm.2017.11.027. Epub 2017 Nov 21.

Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease

Persson K, Barca ML, Cavallin L, Brækhus A, Knapskog AB, Selbæk G, Engedal K.

Acta Radiol. 2018 Aug;59(8):997-1001. doi: 10.1177/0284185117743778. Epub 2017 Nov 27.

Membrane Aging as the Real Culprit of Alzheimer's Disease: Modification of a Hypothesis

Yu Q, Zhong C.

Neurosci Bull. 2018 Apr;34(2):369-381. doi: 10.1007/s12264-017-0192-4. Epub 2017 Nov 24.

Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease

Seo EJ, Fischer N, Efferth T.

Pharmacol Res. 2018 Mar;129:262-273. doi: 10.1016/j.phrs.2017.11.030. Epub 2017 Nov 24.

Intranasal insulin in Alzheimer's disease: Food for thought

Chapman CD, Schiöth HB, Grillo CA, Benedict C.

Neuropharmacology. 2018 Jul 1;136(Pt B):196-201. doi: 10.1016/j.neuropharm.2017.11.037. Epub 2017 Nov 24.

Multimedia Aided Consent for Alzheimer's Disease Research

Palmer BW, Harmell AL, Dunn LB, Kim SY, Pinto LL, Golshan S, Jeste DV.

Clin Gerontol. 2018 Jan-Feb;41(1):20-32. doi: 10.1080/07317115.2017.1373177. Epub 2017 Nov 28.

Qualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease: Alzheimer's disease / Analisi qualitativa sulla capacità a prestare consenso al trattamento in pazienti con malattie cronico degenerative neuropsicoorganiche: Demenza di Alzheimer

Carabellese F, Felthous AR, La Tegola D, Piazzolla G, Distaso S, Logroscino G, Leo A, Ventriglio A, Catanesi R.

Int J Soc Psychiatry. 2018 Feb;64(1):26-36. doi: 10.1177/0020764017739642. Epub 2017 Nov 28.

Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer's disease

Sadhukhan P, Saha S, Dutta S, Mahalanobish S, Sil PC.

Pharmacol Res. 2018 Mar;129:100-114. doi: 10.1016/j.phrs.2017.11.028. Epub 2017 Nov 26.

Extracellular Vesicle Biology in Alzheimer's Disease and Related Tauopathy

DeLeo AM, Ikezu T.

J Neuroimmune Pharmacol. 2018 Sep;13(3):292-308. doi: 10.1007/s11481-017-9768-z. Epub 2017 Nov 28.

Optimal mesenchymal stem cell delivery routes to enhance neurogenesis for the treatment of Alzheimer's disease: optimal MSCs delivery routes for the treatment of AD

Park SE, Lee NK, Na DL, Chang JW.

Histol Histopathol. 2018 Jun;33(6):533-541. doi: 10.14670/HH-11-950. Epub 2017 Nov 29.

Microglia in Alzheimer's disease

Hansen DV, Hanson JE, Sheng M.

J Cell Biol. 2018 Feb 5;217(2):459-472. doi: 10.1083/jcb.201709069. Epub 2017 Dec 1.

Peptides isolated from animal venom as a platform for new therapeutics for the treatment of Alzheimer's disease

Camargo LC, Campos GAA, Galante P, Biolchi AM, Gonçalves JC, Lopes KS, Mortari MR.

Neuropeptides. 2018 Feb;67:79-86. doi: 10.1016/j.npep.2017.11.010. Epub 2017 Nov 28.

Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer's disease: A neuropharmacological review of their bioactive constituents

Gorji N, Moeini R, Memariani Z.

Pharmacol Res. 2018 Mar;129:115-127. doi: 10.1016/j.phrs.2017.12.003. Epub 2017 Dec 5.

ATP-binding cassette transporter-2 (ABCA2) as a therapeutic target

Davis W Jr, Tew KD.

Biochem Pharmacol. 2018 May;151:188-200. doi: 10.1016/j.bcp.2017.11.018. Epub 2017 Dec 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias